| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/23/2023 | 36% | Goldman Sachs | $1.9 → $1.7 | Maintains | Neutral |
| 06/08/2023 | 100% | Bernstein | → $2.5 | Initiates Coverage On | → Outperform |
| 05/24/2023 | 100% | HSBC | $3 → $2.5 | Maintains | Buy |
| 05/16/2023 | 60% | Macquarie | → $2 | Upgrades | Underperform → Outperform |
| 05/15/2023 | 68% | Goldman Sachs | $8.8 → $2.1 | Maintains | Neutral |
| 03/14/2023 | 20% | Macquarie | → $1.5 | Downgrades | Neutral → Underperform |
| 03/14/2023 | 140% | HSBC | $4 → $3 | Maintains | Buy |
| 12/01/2022 | 21.6% | Morgan Stanley | $7 → $1.52 | Downgrades | Overweight → Equal-Weight |
| 11/25/2022 | 60% | HSBC | → $2 | Downgrades | Buy → Hold |
| 11/25/2022 | 181.6% | Citigroup | $6.06 → $3.52 | Maintains | Buy |
| 11/25/2022 | 28% | JP Morgan | $6.4 → $1.6 | Downgrades | Overweight → Underweight |
| 11/25/2022 | 12% | Credit Suisse | $1.7 → $1.4 | Downgrades | Neutral → Underperform |
| 07/27/2022 | 412% | Daiwa Capital | → $6.4 | Initiates Coverage On | → Buy |
| 05/27/2022 | 444% | CLSA | $8 → $6.8 | Downgrades | Buy → Outperform |
| 05/09/2022 | 524% | CICC | → $7.8 | Initiates Coverage On | → Outperform |
| 03/09/2022 | 300% | Macquarie | → $5 | Downgrades | Outperform → Neutral |
| 11/02/2021 | 380% | Bernstein | → $6 | Upgrades | Underperform → Market Perform |
| 08/11/2021 | 940% | Morgan Stanley | $14.8 → $13 | Upgrades | Equal-Weight → Overweight |
| 08/02/2021 | 684% | Goldman Sachs | $20.3 → $9.8 | Downgrades | Buy → Neutral |
| 05/14/2021 | 1100% | JP Morgan | $16 → $15 | Upgrades | Neutral → Overweight |
| 05/13/2021 | 1180% | Macquarie | → $16 | Initiates Coverage On | → Outperform |
| 03/26/2021 | 740% | Bernstein | → $10.5 | Initiates Coverage On | → Underperform |
| 12/11/2020 | 1260% | China Renaissance | → $17 | Initiates Coverage On | → Buy |
| 11/24/2020 | 1340% | B of A Securities | → $18 | Initiates Coverage On | → Buy |
| 11/24/2020 | 1180% | Stifel | → $16 | Initiates Coverage On | → Hold |
| 11/24/2020 | — | Morgan Stanley | Initiates Coverage On | → Equal-Weight | |
| 11/24/2020 | 1500% | Goldman Sachs | → $20 | Initiates Coverage On | → Buy |
| 11/24/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight |
What is the target price for Lufax Holding (LU)?
The latest price target for Lufax Holding (NYSE: LU) was reported by Goldman Sachs on August 23, 2023. The analyst firm set a price target for $1.70 expecting LU to rise to within 12 months (a possible 36.00% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lufax Holding (LU)?
The latest analyst rating for Lufax Holding (NYSE: LU) was provided by Goldman Sachs, and Lufax Holding maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Lufax Holding (LU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lufax Holding, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lufax Holding was filed on August 23, 2023 so you should expect the next rating to be made available sometime around August 23, 2024.
Is the Analyst Rating Lufax Holding (LU) correct?
While ratings are subjective and will change, the latest Lufax Holding (LU) rating was a maintained with a price target of $1.90 to $1.70. The current price Lufax Holding (LU) is trading at is $1.25, which is out of the analyst's predicted range.